According to multiple reports, two people in Denmark suffered brain haemorrhages after receiving AstraZeneca’s COVID-19 vaccine.
Two hospital employees received the vaccine less than 14 days before having a brain bleed, Reuters reportedThe Danish Medicines Agency confirmed that it had received two “serious reports”, but did not provide further details on the matter.
The New York Times reported that one of the patients died, and the other, a woman in her thirties, is seriously ill.
The Hill has contacted AstraZeneca for comment.
The reports are the latest amid a string of media reports from a small number of people who developed blood clots after shots of the AstraZeneca vaccine. The news also represents the second death in Denmark after being given the vaccine from the British-Swedish company.
Denmark discontinued use of the vaccine on March 11 after a 60-year-old woman died of a blood clot after the injection. Other countries, including Germany, France, Italy, Spain, Ireland, and Norway, have also blocked its use.
The vaccine has yet to be approved by the U.S. Food and Drug Administration.
AstraZeneca said last Sunday that there was no evidence that the vaccine was associated with blood clots after review of 17 million shots administered across Europe.
The European Medicines Agency, the European Union’s medicines regulator, said Thursday that the AstraZeneca vaccine is safe and effective to use, but does not rule out an association with blood clots. The agency said it would add a warning to the product about the possibility of the side effect.
Reuters noted that some countries have reversed their decisions amid the EMA’s announcement.
The World Health Organization has recommended that countries will continue to use the vaccine and say the benefits of the vaccine outweigh the risks.